In contrast, the presence of a BRAF mutation in metastatic melanoma is associated with a poorer survival from time of first metastasis (Long et al, 2010) or time from first resected metastasis (Houben et al, 2004), although not consistently observed in smaller studies (Ugurel et al, 2007). Here, BRAF is linked to metastatic melanoma.